Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 10.56 is 43% below its 5-year average of 18.41, near the low end of its 5-year range (9.87–25.47).
6.24% above its 12-month average of 9.94.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 5.79.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:35.677Z. Historical observations retain their original dates. Historical series through 2026-09-10.
EARNINGS PER SHARE (EPS)
10.56
EARNINGS PER SHARE (EPS) AVG TTM
9.94
EARNINGS PER SHARE (EPS) AVG 3Y
15.54
EARNINGS PER SHARE (EPS) AVG 5Y
18.41
EARNINGS PER SHARE (EPS) AVG 10Y
15.68
EARNINGS PER SHARE (EPS) AVG 15Y
13.15
EARNINGS PER SHARE (EPS) AVG 20Y
10.97
CURRENT VS TTM AVG
+6.24%
CURRENT VS 3Y AVG
-32.06%
CURRENT VS 5Y AVG
-42.62%
CURRENT VS 10Y AVG
-32.64%
CURRENT VS 15Y AVG
-19.70%
CURRENT VS 20Y AVG
-3.74%
Humana Inc.
Market Cap
$49.21B
Earnings Per Share (EPS)
10.56
TTM Avg
9.94
3Y Avg
15.54
5Y Avg
18.41
Market Cap
$49.00B
Earnings Per Share (EPS)
3.32
TTM Avg
5.86
3Y Avg
5.65
5Y Avg
5.38
Market Cap
$48.58B
Earnings Per Share (EPS)
1.74
TTM Avg
4.41
3Y Avg
3.40
5Y Avg
2.89
Market Cap
$54.94B
Earnings Per Share (EPS)
7.23
TTM Avg
6.88
3Y Avg
4.62
5Y Avg
2.87
Market Cap
$43.20B
Earnings Per Share (EPS)
0.60
TTM Avg
-0.11
3Y Avg
-0.73
5Y Avg
-1.03
Market Cap
$43.09B
Earnings Per Share (EPS)
8.06
TTM Avg
7.74
3Y Avg
7.17
5Y Avg
5.87
Market Cap
$41.50B
Earnings Per Share (EPS)
5.08
TTM Avg
4.52
3Y Avg
4.36
5Y Avg
3.96
Market Cap
$57.13B
Earnings Per Share (EPS)
-7.98
TTM Avg
-8.27
3Y Avg
-1.90
5Y Avg
3.46
Market Cap
$39.81B
Earnings Per Share (EPS)
14.12
TTM Avg
11.97
3Y Avg
10.56
5Y Avg
9.63
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humana Inc. (HUM) | $49.21B | 10.56 | 9.94 | 15.54 | 18.41 |
| Becton, Dickinson and Company (BDX)vs › | $49.00B | 3.32 | 5.86 | 5.65 | 5.38 |
| Edwards Lifesciences Corporation (EW)vs › | $48.58B | 1.74 | 4.41 | 3.40 | 2.89 |
| Cardinal Health, Inc. (CAH)vs › | $54.94B | 7.23 | 6.88 | 4.62 | 2.87 |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $43.20B | 0.60 | -0.11 | -0.73 | -1.03 |
| IQVIA Holdings Inc. (IQV)vs › | $43.09B | 8.06 | 7.74 | 7.17 | 5.87 |
| Agilent Technologies, Inc. (A)vs › | $41.50B | 5.08 | 4.52 | 4.36 | 3.96 |
| Moderna, Inc. (MRNA)vs › | $57.13B | -7.98 | -8.27 | -1.90 | 3.46 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $39.81B | 14.12 | 11.97 | 10.56 | 9.63 |
| Cencora, Inc. (COR)vs › | $62.57B | 13.46 | 7.81 | 8.10 | 3.88 |
Trailing EPS (TTM)
$10.56
Forward EPS (Est.)
$9.15
P/E Ratio
38.8
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 9.87 |
| 2024-12-31 | 10.01 |
| 2023-12-31 | 20.09 |
| 2022-12-31 | 22.20 |
| 2021-12-31 | 22.79 |
| 2020-12-31 | 25.47 |
| 2019-12-31 | 20.19 |
| 2018-12-31 | 12.24 |
| 2017-12-31 | 16.94 |
| 2016-12-31 | 4.11 |
| 2015-12-31 | 8.54 |
| 2014-12-31 | 7.44 |
| 2013-12-31 | 7.82 |
| 2012-12-31 | 7.57 |
| 2011-12-31 | 8.58 |
| 2010-12-31 | 6.55 |
| 2009-12-31 | 6.21 |
| 2008-12-31 | 3.87 |
| 2007-12-31 | 5.00 |
| 2006-12-31 | 2.97 |
| 2005-12-31 | 1.91 |
| 2004-12-31 | 1.75 |
| 2003-12-31 | 1.41 |
| 2002-12-31 | 0.85 |
| 2001-12-31 | 0.71 |
| 2000-12-31 | 0.54 |
| 1999-12-31 | -2.28 |
| 1998-12-31 | 0.77 |
| 1997-12-31 | 1.06 |
| 1996-12-31 | 0.07 |
